The largest database of trusted experimental protocols

Intellipath flx

Manufactured by Biocare Medical
Sourced in United States, Denmark

The IntelliPATH FLX is a versatile and automated slide staining system designed for clinical diagnostic laboratories. It offers a range of features to streamline and optimize the slide staining process, including automated slide loading, staining, and unloading capabilities. The system is designed to provide consistent and reliable results, supporting various staining protocols and applications.

Automatically generated - may contain errors

17 protocols using intellipath flx

1

Comprehensive Immunohistochemical Evaluation of Tumor Xenografts

Check if the same lab product or an alternative is used in the 5 most similar protocols
The method was performed as we described before (16 (link)), briefly, the tumors were fixed in 4% formaldehyde solution for 48 h, followed by routine dehydration, paraffin embedding and section. Hematoxylin-eosin (HE) staining was performed on Dako CoverStainer (Agilent Technologies, Inc., California, USA). IHC staining was performed on intelliPATH FLX (BIOCARE MEDICAL, LLC, California, USA) with Polymer Immunohistochemical Detection System (Wuxi OriGene Technologies, Inc., Wuxi, China). Primary antibodies, including anti-Calretinin, -Cytokeratin 5/6, -WT-1, -Ki-67 and -VEGFR-2 antibody (OriGene, Poly), were used for IHC analysis. Images were captured using Zeiss Axio Scope.A1. The positive rates of Ki-67 and VEGFR-2 were calculated by using Image-pro plus.
For toxicity evaluation, the organs of nude mice were harvested and fixed in 4% formaldehyde solution for 48 h. HE staining was performed according to the method described above. Blank control group was used as normal control, and abnormal histological signs under the microscope were considered as toxic reaction. All HE and IHC sections were reviewed by 3 senior pathologists who were blind to the design of the study.
+ Open protocol
+ Expand
2

Standardized Celiac Disease Diagnosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Biopsies were assessed by a single experienced pathologist, blinded to all case data, in accordance with instructions for quality assurance and standardization assembled by the Swedish Society of Pathology. The status of the villi and crypts and the number of IELs were assessed for each biopsy. In cases where hematoxylin-eosin staining revealed an IEL number close to the ULN (25 IELs per 100 epithelial cells), an additional staining for CD3 was performed to better assess the number of IELs; when using CD3 staining, there should be >30 IELs per 100 epithelial cells to be indicative of CD. Hematoxylin-eosin staining was performed using the Tissue-Tek DRS 2000 Slide Stainer (Sakura, Alphen aan den Rijn, The Netherlands), and CD3 staining was performed using antibodies against CD3 (Dako, Glostrup, Denmark) and intelliPATH FLX (Biocare Medical, Concord, CA). The histological changes were reported according to the modified Marsh scale (0, 1, 2, 3A, 3B, or 3C) [16 (link)].
+ Open protocol
+ Expand
3

Automated Quantification of Tumor Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumor sample sections for IHC were stained on the IntelliPATH FLX automated stainer (Biocare Medical) for Ki67 (Abcam PLC; #ab15580), caspase-3 (CST; #9661T), HER2 (Biocare; #ACA342B), phospho-HER2 (CST; #2243S), phospho-HER3 (CST; #2842S), phospho-AKT (CST; #3787L), and phospho-ERK (CST; #4370L).
Slides were digitized at 20X magnification to produce whole slide images (WSIs). WSIs were computationally analyzed using HALO image analysis software v3.1.1076.283 (Indica Labs), which was trained to classify tumor versus stroma. Analysis of tumor markers, including phospho-epitopes, was confined to delineated tumor tissue. All classifications and image analysis markups were assessed visually to verify accuracy. Data were analyzed in Prism and one-way ANOVA performed followed by Dunnett multiple comparison test. Additional method details are available in the Supplementary Materials and Methods.
+ Open protocol
+ Expand
4

Immunohistochemical Analysis of Estrogen Receptors

Check if the same lab product or an alternative is used in the 5 most similar protocols
From each patient, one formalin-fixed paraffin tissue block of the primary tumour and one block of the matching SLN were identified. The sections were cut at 4-μm thickness and mounted. Immunohistochemistry was performed either on an Autostainer (Dako, Glostrup, Denmark; ERβ1) or on IntelliPath FLX (BioCare medical, Concord, CA, USA; ERα and ERβcx) according to the protocols and reagents provided by the manufacturers (BioCare medical and Dako), together with negative and positive controls. Heat-induced antigen retrieval in high pH solution was performed using a PT-linker (Dako) at 97°C for 20 min. The slides were incubated for 30 min at room temperature with the primary monoclonal antibodies. Anti-ERβ1 (clone PPG5/10; Dako) 1 : 50, anti-ERβcx (clone 57/3; AbD Serotec, Oxford, UK) 1 : 200 and anti-ERα (clone NCL-L-ER-6F11; Novocastra, Wetzlar, Germany) 1 : 200 antibodies were used. 3,3′-diaminobenzidine (DAB) was used to detect primary antibody binding and haematoxylin as counterstaining.
+ Open protocol
+ Expand
5

Comprehensive Immunohistochemical Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemical staining was performed in 40 of the 44 cases with PAX8, cytokeratin7 (CK7), cytokeratin 20 (CK20), carcinoembryonic antigen (CEA), epithelial membrane antigen (EMA), estrogen receptor (ER), progesterone receptor (PR), vimentin, CDX2, CD10, Wilm’s tumor 1 (WT1) and p16. A streptavidin-biotin peroxidase complex method was used with appropriate positive and negative controls. An autostainer (Biocare, intelliPATH FLX) was used according to the manufacture’s specifications. The antibodies used and their dilutions are listed in Table 1.
+ Open protocol
+ Expand
6

CXCR4 and CXCL12 Expression in DLBCL

Check if the same lab product or an alternative is used in the 5 most similar protocols
Formalin-fixed, paraffin-embedded tissue was pre-treated in a water bath with Target Retrieval Solution (1:10, Dako, Glostrup, Denmark) for 40 min. Primary antibody to CXCR4 (1:200, order number: ab1640) was purchased from Abcam (Cambridge, UK) and primary antibody to CXCL12 (1:50, order number: MAB350) from R&D Systems (Minneapolis, MN, USA). For staining, kit K5001 (Dako, Glostrup, Denmark) and the automated stainer intelliPATH FLX® (Biocare Medical, Pacheco, CA, USA) were used according to the manufacturer’s instructions. We included tissues known to contain the respective antigens—reactive tonsils—as controls (positive controls). Replacing the primary antibody with normal serum always produced negative results (negative controls). Both negative and positive controls for CXCR4 and CXCL12 are shown in Figure S11a,b. DLBCL specimens were investigated regarding the staining intensities and percentages of the positive stained DLBCL cells according to the following procedure. For determination of the CXCR4 and CXCL12 expression, the whole section was screened for an equal distribution of positive cells. The determination of the percentage was done by calculating the average percentage of cytoplasmic NR4A1 positive cells in at least ten high-power-fields (0.242 mm2 each, field diameter: 555.1 µm). Percentages were rounded to 10%.
+ Open protocol
+ Expand
7

Ki-67 Immunostaining and Hormone Analysis of Follicle Cultivation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The scaffolds were put on glass holders and fixed with an alcoholic fixation solution to prepare them for Ki-67 immunostaining. After rehydration, antigen retrieval was done with heat at pH 6 with target retrieval solution (Dako, Germany, Waldenbronn) according to the manufacturer’s instructions. The immunostaining was conducted on an automated immunohistochemistry staining system (intelli Path FLX, Biocare, USA, Ca, Pacheco) with a mouse anti Ki-67 monoclonal antibody (Zytomed, mouse anti Ki-67 (MSK018) Dako, Germany, Waldenbronn) diluted 1:200 and incubated for 30 minutes at room temperature. For detection the Zytochem-plus HRP kit was used (Zytomed, Germany, Berlin) with incubation times of 20 minutes each from the biotinylated secondary antibody and the Streptavidin conjugate and stained for 12 minutes with a DAB substrate (DAB Substrate Kit, Zytomed, Germany, Berlin) and counterstained with haematoxylin (Dako, Germany, Waldenbronn).
Estradiol and Progesterone concentrations during follicle cultivation with PCL and PCL/gel were evaluated by analyzing removed culture medium during replacement; supernatants from day 2 and day 10 were analyzed in duplicates by using the Access Estradiol and Progesterone Reagent Packs (Beckman Coulter, USA, Ca Brea) with the UniCel DxI 600 Access Immunoassay System (Beckman Coulter, USA, Ca Brea), according to the manufacturer.
+ Open protocol
+ Expand
8

Automated IHC Staining Protocol for Myeloperoxidase

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antigen retrieval was performed by immersing the slides in a citrate buffer and heating them in a pressure cooker (Decloaking Chamber, Biocare Medical). After retrieval, the slides were washed with Tris buffer prior to beginning the immunostaining procedure. The IHC procedure was run on an automated platform (intelliPATH FLX, Biocare Medical). All incubations were carried out at room temperature. Endogenous peroxidase activity was blocked by incubating the slides with 3% hydrogen peroxide for 10 minutes. A non-serum reagent (Background Punisher, Biocare Medical) was used to block non-specific protein binding. The sections were then incubated with the primary antibody (rabbit anti-human myeloperoxidase, dilution 1:1,000, Agilent Technologies) for 30 minutes. Next, the slides were incubated with a polymer detection reagent (Mach 2 Rabbit HRP-Polymer, Biocare Medical) for 25 minutes. Sites of antibody–antigen interaction were visualized by incubating with a DAB chromogen (ImmPACT DAB Substrate kit, peroxidase, Vector Laboratories) for 5 minutes.
+ Open protocol
+ Expand
9

PSMA Expression in Canine Urothelial and Prostate Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell lines were fixed in 10% formalin for 1 hour at room temperature. After 1-hour incubation, cells were washed and pelleted in 2% agarose, then paraffin-embedded. The University of Illinois Veterinary Diagnostic Laboratory database was reviewed for cases of iUC among female dogs (for undisputed iUC confirmation) and carcinomas of the prostate. In total, 12 iUC cases and 10 carcinomas of the prostate were identified to be recut for PSMA immunohistochemistry (IHC). IHC staining was performed using an autostainer (intelliPATH FLX, Biocare, Concord, CA). Samples were deparaffinize in xylene and rehydrated in alcohol. Samples were treated with Diva Decloaker and then blocked with Peroxidazed 1 for 5 minutes. A secondary block with Background Punisher was performed for 10 minutes. Samples were incubated with a mouse monoclonal, anti-human PSMA antibody (Novus Biologicals, NBP1–45057) at 1:1000 dilution for 30 minutes. Samples were washed, incubated with a biotinylated secondary antibody for 30 minutes, washed, then incubated with the chromogen IP FLX DAB. Slides were counterstained with hematoxylin. Well characterized human cell lines served as strong positive (LNCaP) and negative/weak positive (PC-3) PSMA controls.
+ Open protocol
+ Expand
10

Quantitative Pancreatic Insulin Immunohistochemistry

Check if the same lab product or an alternative is used in the 5 most similar protocols
After completing the ex vivo imaging each pancreas was immersed in 10% buffered formalin, fixed for 24–48 h, and routinely processed and embedded in paraffin. Four-micron thick sections were generated at 50-micron intervals through the paraffin block until the entire tissue block was exhausted, resulting in 11–20 separate levels depending upon the size of the pancreas. To identify pancreatic β-cells, one section from each 50-micron interval of each pancreas was immunostained using a murine reactive guinea pig anti-insulin antibody (ab7842; Abcam, Inc., Cambridge MA). For the entire study 635 slides were immunostained. Staining was performed on an automated immunostainer (intelliPATH FLX, BioCare Medical, Concord CA). Briefly, after removal of paraffin in xylene and hydrating the sections through graded ethanols, endogenous peroxidase was blocked by incubation in 3.0% H2O2. Non-specific binding sites were blocked by incubation with protein blocking solution (Sniper, BioCare) followed by incubation with the anti-insulin antibody (1∶50; 60 min RT). Sections were subsequently incubated with peroxidase-conjugated goat anti-guinea pig IgG F(ab')2 antibody (#106-036-003; 1∶1000; 30 min RT, Jackson ImmunoResearch Labs, Inc., West Grove PA) and 3,3′-diaminobenzidine (DAB) chromogen. Sections were counterstained with hematoxylin.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!